Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2008

View Archived Issues

Novel oncolytic MP-529 shows activity in vivo

Lodamin formulation allows oral administration of the antiangiogenic TNP-470

Higher immunogenicity for novel quadrivalent meningoccocal vaccine in phase III study

Recent patent literature discloses new treatment options for cancer

Inhibition of gap junction signaling protects retinal cells against ischemia-induced apoptosis

Spotlight on ranibizumab phase III trials for AMD

Regeneron's angiopoietin-2 neutralizing antibody promotes CNV regression

NicOx initiates first phase I study for nitric oxide-donating agent in hypertension

Pharmexa stops one of two phase III trials for GV-1001

Starpharma presents positive VivaGel clinical study results

SpectRx changes name to Guided Therapeutics

Orion discontinues development of new COMT inhibitor for Parkinson's disease

FDA delays issuing of action letter on Adolor's NDA for Entereg in postoperative ileus

Roche reports results from LITHE phase III trial of Actemra in RA

FDA grants priority review of Gamunex as treatment for neurological disorder CIDP

Recent Astellas patent describes new compounds for treating urinary incontinence

NIH awards grant to LIAI grant to test anti-H3 antibody treatment against smallpox

New antibacterial agents reported in recent LEK and LICA patents

Savient reports positive interim data from open-label extension to phase III trials of Puricase

Oxford BioMedica presented update

Novelos presents positive results in ongoing phase II neoadjuvant breast cancer trial

Proellex shows no adverse cardiac effects in a pilot trial

Argos initiates phase II proof-of-concept trial for AGS-004 in HIV

ImmuPharma received approval for IPP-201101 trademark Lupuzor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...